JPRN-UMIN000011442招募中未知
Study of therapy with zoledronic acid in prostate cancer patients with bone metastases. - Study of therapy with zoledronic acid in prostate cancer patients with bone metastases.
Osaka University Graduate School of Medicine,Department of Organ Specific Regulation (Urology)0 个研究点目标入组 200 人开始时间: 2013年8月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)Patients who have contraindications to zoledronic acid. 2)Patients without improvement of surgical wounds after invasive dental treatment. 3)Patients who have previously received zoledronic acid or denosumab. 4)Serum creatinine: more than 3.0mg/dL 5) Patient judged inappropriate for this study by the physicians
研究者
相似试验
已完成
2 期
Efficacy and Safety of Zoledronic acid on urological cancer patients with bone metastasis: a phase II clinical study.rological Cancer with bone metastasis (Hormone resistant prostate cancer, Kidney cancer, urothelial cancer, kidney pelvis and ureteral cancer)JPRN-UMIN000002291Department of Urology, Graduate School of Medical Sciences, Kyushu University100
已完成
4 期
Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasisProstate Cancer Patients With Bone MetastasisNCT00237159Novartis Pharmaceuticals284
尚未招募
不适用
Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patientsMultiple MyelomaJPRN-UMIN000002158Division of clinial oncology and hematology, Jikei University School of Medicine5
招募中
2 期
SBP-15ER positive early breast canceraromatase inhibitors induced osteoporosisJPRN-jRCT1061210010Tadahiko Shien200
进行中（未招募）
1 期
Zoledronic acid in the management of Mesothelioma - a feasibility trialMalignant pleural mesotheliomaMedDRA version: 19.0 Level: PT Classification code 10027406 Term: Mesothelioma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0 Level: PT Classification code 10035603 Term: Pleural mesothelioma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0 Level: PT Classification code 10059518 Term: Pleural mesothelioma malignant System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004433-26-GBorth Bristol NHS Trust22